MedPath

Iron Status and Myelination in Premature Infants

Not Applicable
Completed
Conditions
Neurodevelopmental Outcome
Registration Number
NCT00684697
Lead Sponsor
University of Rochester
Brief Summary

Premature infants with iron deficiency if supplemented with more elemental iron than the routine 2mg/kg/day will have improved brain development.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Babies less than or equal to 33 weeks gestational age
Exclusion Criteria
  • Infants with cranio-facial malformations
  • Torch infections
  • Infants with hearing disorders
  • Infants receiving erythropoietin
  • Infants with subnormal vitamin E levels
  • Infants with severe anemia
  • Infants who are not on full feeds
  • Infant with in-utero exposure to cocaine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
mean interpeak latency Auditory Neural Myelination43-45 weeks PMA

This will be measured using auditory brain stem response.

mean visual neural myelination43-45 weeks PMA

Visual myelination will be evaluated by visual evoked response.

Secondary Outcome Measures
NameTimeMethod
number of participants with executed function3-5 years

Using a standardize test.

Trial Locations

Locations (1)

University of Rochester Medical Center

🇺🇸

Rochester, New York, United States

University of Rochester Medical Center
🇺🇸Rochester, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.